Gastrointestinal Tumor: Clinical Trials

6 trials for Gastrointestinal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 3, Recruiting 3
Phase 21Completed 1

Follow Gastrointestinal Tumor: new trials by email Literature Review of Gastrointestinal Tumor trials Research Report on Gastrointestinal Tumor

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
SI-B036 - Gastrointestinal Tumor, Solid Tumor
Phase 1RecruitingSichuan Baili Pharmaceutical Co., Ltd.102026-07-302026-09-04
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
BL-M09D1 - Gastrointestinal Tumor, Solid Tumor
Phase 1RecruitingSichuan Baili Pharmaceutical Co., Ltd.452025-05-152025-05-31
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
BL-B01D1 - Gastrointestinal Tumor
Phase 1RecruitingSichuan Baili Pharmaceutical Co., Ltd.962022-02-142026-08-27
Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours
Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany), tislelizumab (BeiGene, China) combined with PD-1 inhibitor - Gastrointestinal Tumor
Phase 1 / Phase 2CompletedPengyuan Liu182020-06-012023-09-05
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
alemtuzumab, fludarabine, sirolimus - Ewing Sarcoma, Gastrointestinal Tumor
Phase 1CompletedSt. Jude Children's Research Hospital232012-08-202026-02-06
Phase I Trial of Combination of FOLFIRI and SOM 230
SOM230C LAR, FOLFIRI Infusion - Gastrointestinal Tumor
Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute162011-09-012015-12-24

Narrower conditions

Digestive System Neoplasms (6)  ·  Adenocarcinoma, Clear Cell (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Hyperthermia (1)  ·  Lymphoma (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neuroblastoma (1)  ·  Pancreatic Neoplasms (1)  ·  Rhabdoid Tumor (1)  ·  Rhabdomyosarcoma (1)

Broader conditions

Digestive System Diseases (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Adenocarcinoma (1)  ·  Body Temperature Changes (1)  ·  Carcinoma (1)  ·  Colonic Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Esophageal Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)

Interventions

Alemtuzumab (1)  ·  Busulfan (1)  ·  Fluorouracil (1)  ·  Immune Checkpoint Inhibitors (1)  ·  Irinotecan (1)  ·  Leucovorin (1)  ·  Melphalan (1)  ·  Sirolimus (1)  ·  Stem Cell Transplantation (1)  ·  fludarabine (1)  ·  spartalizumab (1)  ·  tislelizumab (1)

Sponsors

Sichuan Baili Pharmaceutical Co., Ltd. (3)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Pengyuan Liu (1)  ·  St. Jude Children's Research Hospital (1)

Countries

China (4)  ·  United States (2)

Top investigators

Brando Triplett, MD (1)  ·  Jun Chen (1)  ·  Lin Shen, PHD (1)  ·  Richard Kim, M.D. (1)

Results publications

PMID 40640393